Valuation: Vivos Therapeutics, Inc.

Market Cap 5.46M 4.8M 4.46M 4.09M 7.69M 526M 7.81M 52.98M 20.7M 259M 20.5M 20.06M 894M P/E 2026 *
-0.28x
P/E 2027 * -0.5x
Enterprise Value 5.46M 4.8M 4.46M 4.09M 7.69M 526M 7.81M 52.98M 20.7M 259M 20.5M 20.06M 894M EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.16x
Free-Float
73.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.64%
1 week-6.29%
Current month-13.51%
1 month-9.42%
3 months-53.34%
6 months-77.79%
Current year-80.64%
1 week 0.36
Extreme 0.3637
0.44
1 month 0.36
Extreme 0.3637
0.55
Current year 0.36
Extreme 0.3637
2.69
1 year 0.36
Extreme 0.3637
5.69
3 years 0.36
Extreme 0.3637
48.79
5 years 0.36
Extreme 0.3637
177.25
10 years 0.36
Extreme 0.3637
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap.
30/06/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
30/06/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
04/02/26 Other

Director

3,997 0.0424%
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%-6.29%-92.50%-94.64% 5.46M
+0.26%+0.13%+36.74%+5.60% 12.54B
+0.52%-0.95%+14.24%+19.11% 6.47B
-0.53%-5.32%+40.76%+18.75% 5.48B
+3.06%-0.59% - - 4.73B
-3.39%+1.63%-27.68%+19.43% 4.32B
-2.85%-2.49%-25.86%-23.96% 3.92B
-11.71%+10.87%+46.59%-54.71% 2.06B
-0.34%-4.23%-11.45%+197.57% 1.72B
+0.33%+0.33%+55.09%-5.26% 1.55B
Average -1.40%-1.60%+3.99%+9.10% 4.28B
Weighted average by Cap. -0.74%-1.46%+18.81%+13.26%

Financials

2026 *2027 *
Net sales 24.06M 21.13M 19.65M 18.03M 33.88M 2.32B 34.4M 233M 91.16M 1.14B 90.3M 88.36M 3.94B 34.09M 29.94M 27.84M 25.55M 48.01M 3.28B 48.75M 331M 129M 1.61B 128M 125M 5.58B
Net income -23.82M -20.92M -19.45M -17.85M -33.54M -2.29B -34.06M -231M -90.25M -1.13B -89.41M -87.48M -3.9B -13.78M -12.11M -11.26M -10.33M -19.41M -1.33B -19.71M -134M -52.23M -653M -51.75M -50.63M -2.26B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
24/07/26 $0.3931 +0.64% 152,919
23/07/26 $0.3906 -3.32% 285,688
22/07/26 $0.4040 -2.60% 125,222
21/07/26 $0.4148 +0.88% 111,004
20/07/26 $0.4112 -1.98% 70,960
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3931USD
Average target price
2.117USD
Spread / Average Target
+438.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock